谷歌浏览器插件
订阅小程序
在清言上使用

Two-year Analysis of Efficacy and Safety Data from Black and Hispanic People with Relapsing Multiple Sclerosis Receiving Ocrelizumab Treatment in the CHIMES Trial

MULTIPLE SCLEROSIS JOURNAL(2024)

引用 0|浏览29
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要